- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 309/22 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 309/22
Total number of patents in this class: 38
10-year publication summary
|
1
|
2
|
5
|
5
|
4
|
3
|
1
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4751 |
8 |
| Jiangsu Hecheng Display Technology Co., Ltd. | 194 |
3 |
| Astellas Pharma Inc. | 1043 |
2 |
| Jazz Pharmaceuticals Research UK Limited | 257 |
2 |
| Novartis AG | 10251 |
1 |
| BASF SE | 21308 |
1 |
| The Regents of the University of California | 20778 |
1 |
| Janssen Pharmaceutica N.V. | 3162 |
1 |
| Syngenta Participations AG | 1516 |
1 |
| Syngenta Limited | 426 |
1 |
| Bayer Intellectual Property GmbH | 2363 |
1 |
| Children's Medical Center Corporation | 1957 |
1 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
1 |
| Les Laboratoires Servier | 498 |
1 |
| Medshine Discovery Inc. | 588 |
1 |
| Orion Corporation | 773 |
1 |
| Oxford University Innovation Limited | 1666 |
1 |
| Rutgers, The State University of New Jersey | 1972 |
1 |
| Umicore AG & Co. KG | 854 |
1 |
| Vanderbilt University | 2022 |
1 |
| Other owners | 7 |